163 related articles for article (PubMed ID: 23749058)
1. Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.
Cheng D; Kong H; Li Y
Eur Arch Otorhinolaryngol; 2014 Mar; 271(3):503-9. PubMed ID: 23749058
[TBL] [Abstract][Full Text] [Related]
2. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma fibrinogen level shows superior prognostic value than Epstein-Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
Lan M; Chen C; Huang Y; Mao M; Han F; Liao J; Deng M; Duan Z; Zheng L; Wu S; Lu T; Jian Y
Oncotarget; 2016 Jul; 7(29):46242-46252. PubMed ID: 27323828
[TBL] [Abstract][Full Text] [Related]
4. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.
Feng X; Lin J; Xing S; Liu W; Zhang G
BMC Cancer; 2017 Jan; 17(1):90. PubMed ID: 28143425
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma.
Liu Z; Li L; Yang Z; Luo W; Li X; Yang H; Yao K; Wu B; Fang W
BMC Cancer; 2010 Jun; 10():270. PubMed ID: 20534121
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma.
Wong TS; Kwong DL; Sham JS; Wei WI; Kwong YL; Yuen AP
Eur J Surg Oncol; 2004 Jun; 30(5):560-4. PubMed ID: 15135487
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis.
Qi X; Li X; Sun X
Tumour Biol; 2016 Aug; 37(8):11099-104. PubMed ID: 26910773
[TBL] [Abstract][Full Text] [Related]
8. MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma.
He JR; Qin H; Ren ZF; Cui C; Zhang Y; Ranatunga D; Zeng YX; Jia WH
Clin Chem Lab Med; 2011 Apr; 49(4):705-10. PubMed ID: 21231907
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma].
Li YH; Shao JY; Li S; Zou BY; Huang HQ; Guan ZZ
Ai Zheng; 2004 Sep; 23(9):1060-4. PubMed ID: 15363202
[TBL] [Abstract][Full Text] [Related]
10. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma.
Luo XL; Zhong GZ; Hu LY; Chen J; Liang Y; Chen QY; Liu Q; Rao HL; Chen KL; Cai QQ
Oncotarget; 2015 Dec; 6(41):44037-48. PubMed ID: 26503474
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed immunobead-based profiling of cytokine markers for detection of nasopharyngeal carcinoma and prognosis of patient survival.
Chang KP; Chang YT; Wu CC; Liu YL; Chen MC; Tsang NM; Hsu CL; Chang YS; Yu JS
Head Neck; 2011 Jun; 33(6):886-97. PubMed ID: 21560180
[TBL] [Abstract][Full Text] [Related]
13. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
[TBL] [Abstract][Full Text] [Related]
14. IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.
Zergoun AA; Zebboudj A; Sellam SL; Kariche N; Djennaoui D; Ouraghi S; Kerboua E; Amir-Tidadini ZC; Chilla D; Asselah F; Touil-Boukoffa C; Merghoub T; Bourouba M
Tumour Biol; 2016 Mar; 37(3):3505-14. PubMed ID: 26453114
[TBL] [Abstract][Full Text] [Related]
15. Plasma adrenomedullin levels and nasopharyngeal carcinoma prognosis.
Zhang ZL; Huang SX; Lin S; Chai L
Clin Chim Acta; 2015 Feb; 440():172-6. PubMed ID: 25433141
[TBL] [Abstract][Full Text] [Related]
16. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.
Lu X; Qian CN; Mu YG; Li NW; Li S; Zhang HB; Li SW; Wang FL; Guo X; Xiang YQ
Eur J Cancer; 2011 Feb; 47(3):339-46. PubMed ID: 20951575
[TBL] [Abstract][Full Text] [Related]
17. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment interleukin 6 and clinical stage.
Ke L; Xiang Y; Xia W; Yang J; Yu Y; Ye Y; Liang H; Guo X; Lv X
Clin Immunol; 2016 Mar; 164():45-51. PubMed ID: 26780676
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases.
Wei Z; Zeng X; Xu J; Duan X; Yang J; Xie Y
Head Neck; 2014 Jan; 36(1):71-6. PubMed ID: 23728904
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma.
Mo HY; Luo DH; Qiu HZ; Liu H; Chen QY; Tang LQ; Zhong ZL; Huang PY; Zhao ZJ; Zhang CQ; Zhang Y; Mai HQ
Clin Oncol (R Coll Radiol); 2013 May; 25(5):308-17. PubMed ID: 23290342
[TBL] [Abstract][Full Text] [Related]
20. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.
Kontos CK; Fendri A; Khabir A; Mokdad-Gargouri R; Scorilas A
BMC Cancer; 2013 Jun; 13():293. PubMed ID: 23777485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]